Cargando…
Biomarkers of Acute Lung Injury The Individualized Approach: for Phenotyping, Risk Stratification and Treatment Surveillance
Do we need biomarkers of lung damage and infection: For what purpose and how should they be used properly? Biomarkers of lung damage can be used for diagnosis, risk stratification/prediction, treatment surveillance and adjustment of targeted therapy. Additionally, novel “omics” methods may offer a c...
Autores principales: | Murray, Daniel D., Itenov, Theis Skovsgaard, Sivapalan, Pradeesh, Eklöf, Josefin Viktoria, Holm, Freja Stæhr, Schuetz, Philipp, Jensen, Jens Ulrik |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6722821/ https://www.ncbi.nlm.nih.gov/pubmed/31382587 http://dx.doi.org/10.3390/jcm8081163 |
Ejemplares similares
-
Acute Lung Injury in Critically Ill Patients: Actin-Scavenger Gelsolin Signals Prolonged Respiratory Failure
por: Holm, Freja Stæhr, et al.
Publicado: (2019) -
Sepsis: Personalized Medicine Utilizing ‘Omic’ Technologies—A Paradigm Shift?
por: Itenov, Theis Skovsgaard, et al.
Publicado: (2018) -
SARS-CoV-2 and risk of psychiatric hospital admission and use of psychopharmaceuticals: A nationwide registry study of 4,585,083 adult Danish citizens
por: Rømer, Valdemar, et al.
Publicado: (2023) -
Inhalation devices and inhaled corticosteroids particle size influence on severe pneumonia in patients with chronic obstructive pulmonary disease: a nationwide cohort study
por: Heerfordt, Christian Kjer, et al.
Publicado: (2023) -
Roflumilast in Severely Ill Patients with Chronic Obstructive Pulmonary Disease with Frequent Exacerbations: Risk of Pneumonia Hospitalization and Severe Exacerbations
por: Alispahic, Imane Achir, et al.
Publicado: (2020)